What are the main challenges surrounding primary prevention trials for Alzheimer’s? Should researchers be exploring alternative avenues to amyloid-β in these trials? Take a look at our interview with Randall Bateman to find out more.
At the Glial meeting in Portugal, we had the fantastic opportunity of interviewing Pascale Eede and Verena Haage about their research with astrocytes and microglia, as well as their experiences on acquiring viable glial cells from adult brain tissues.
Webinar live date: 07:00 [PDT] 10:00 [EDT] 15:00 [BST]. A comprehensive look at the evolving requirements for early phase CNS drug and cannabinoid development, with recommendations for regulatory strategy and marketing success.
In this interview from the Video Journal of Biomedicine, Hannah Brown (Ipsos Healthcare, London, UK) discusses physician and patient treatment decision-making for relapsing–remitting multiple sclerosis.
What are the challenges surrounding clinical trial design for genetic therapies in terms of neurodegenerative diseases? What technological advances could help bring these therapies to the clinic more quickly? Find out in our video interview with Sarah Tabrizi.
Genetic therapies represent a remarkable avenue for potentially slowing and preventing neurodegenerative diseases. This includes a first-in-human, gene-silencing treatment for Alzheimer’s disease. Find out more on this from Catherine Mummery.
In this video, we spoke with Henrik Zetterberg to find out how challenges with replication, reproducibility and specificity could be addressed in the field.
As part of our Spotlight on organoids, we carried out a survey to gain an insight into how organoids are being used as a research tool in the lab, the challenges involved in organoid research and what researchers thought about the terms ‘mini-brains’ and ‘brains in a dish’. Find out the results in this informative infographic.
In a revolutionary approach, Cognetivity (London, UK) have created a new test for detecting dementia and Alzheimer’s disease by focusing on image cognition and the brain’s ability to analyze visual information.
The BioTechniques editorial team talk to Jenny Straiton about her recent Tech News piece on cerebral organoids and the history of neuroscience.